Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VT-X7 irrigation for hip/knee periprosthetic joint infection
NCT05607030Phase 2Completed
- Sponsor
- Osteal Therapeutics
- Start
- Jan 2023
- Primary completion
- May 2024
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vancomycin, tobramycin in periprosthetic joint infection (PJI), sponsored by Osteal Therapeutics. Started Jan 2023; status: completed.
02
Drugs
vancomycintobramycin
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT05607030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05607030.